Common Contracts
12 similar Credit Agreement contracts by Establishment Labs Holdings Inc., Biocryst Pharmaceuticals Inc, Calliditas Therapeutics AB, others
ContractCredit Agreement • May 9th, 2024 • Zevra Therapeutics, Inc. • Pharmaceutical preparations • New York
Pursuant to Item 601(b)(2)(ii), certain identified information marked with [***] has been excluded from this exhibit because it is both not material and is the type that the registrant customarily and actually treats as private or confidential.
CREDIT AGREEMENT Dated as of December 27, 2023 among CALLIDITAS THERAPEUTICS AB, as the Borrower, CERTAIN SUBSIDIARIES OF THE BORROWER, as the Guarantors, ATHYRIUM OPPORTUNITIES IV CO-INVEST 1 LP, as the Administrative Agent and THE LENDERS FROM TIME...Credit Agreement • April 24th, 2024 • Calliditas Therapeutics AB • Pharmaceutical preparations • New York
This CREDIT AGREEMENT is entered into as of December 27, 2023 among CALLIDITAS THERAPEUTICS AB, a Swedish public limited liability company with Swedish registration number 556659-9766 (the “Borrower”), the Guarantors (defined herein), the Lenders (defined herein) and ATHYRIUM OPPORTUNITIES IV CO-INVEST 1 LP, as the Administrative Agent.
CREDIT AGREEMENTCredit Agreement • November 1st, 2022 • Stronghold Digital Mining, Inc. • Services-computer processing & data preparation • New York
Credit Agreement, dated as of October 27, 2022 (the “Agreement”), by and among Stronghold Digital Mining Holdings LLC, a Delaware limited liability company (the “Borrower”) Stronghold Digital Mining, Inc., a Delaware corporation (“Holdings”), each Subsidiary of the Borrower listed as a “Guarantor” on the signature pages hereto (together with Holdings and each other Person that executes a joinder agreement and becomes a “Guarantor” hereunder or otherwise guaranties all or any part of the Obligations (as hereinafter defined), each a “Guarantor” and collectively, the “Guarantors”), Whitehawk Finance LLC and/or its Affiliates or designees and the other lenders from time to time party hereto (each a “Lender” and collectively, the “Lenders”), Whitehawk Capital Partners LP (“Whitehawk Capital”), as collateral agent for the Lenders (in such capacity, together with its designees, successors and assigns, the “Collateral Agent”) and Whitehawk Capital, as administrative agent for the Lenders (in s
Certain information has been omitted from this exhibit in places marked “[***]” because it is both not material and would likely cause competitive harm to the registrant if publicly disclosed. In addition, certain personally identifiable information...Credit Agreement • February 28th, 2022 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This CREDIT AGREEMENT is entered into as of December 7, 2020 among BIOCRYST PHARMACEUTICALS, INC., a Delaware corporation (the “Borrower”), the Guarantors (defined herein) listed on the signature pages hereto and from time to time party hereto, the Lenders (defined herein) from time to time party hereto and ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP, a Delaware limited partnership, as Administrative Agent for the Lenders (each as defined below).
Certain information has been omitted from this exhibit in places marked “[***]” because it is both not material and would likely cause competitive harm to the registrant if publicly disclosed or because it contains personally identifiable information...Credit Agreement • November 12th, 2021 • Cti Biopharma Corp • Pharmaceutical preparations • New York
Certain information has been omitted from this exhibit in places marked “[***]” because it is both not material and would likely cause competitive harm to the registrant if publicly disclosed or because it contains personally identifiable information...Credit Agreement • March 1st, 2021 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This CREDIT AGREEMENT is entered into as of December 7, 2020 among BIOCRYST PHARMACEUTICALS, INC., a Delaware corporation (the “Borrower”), the Guarantors (defined herein) listed on the signature pages hereto and from time to time party hereto, the Lenders (defined herein) from time to time party hereto and ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP, a Delaware limited partnership, as Administrative Agent for the Lenders (each as defined below).
EXECUTION VERSION FOURTH AMENDMENT TO CREDIT AGREEMENT THIS FOURTH AMENDMENT TO CREDIT AGREEMENT (this “Agreement”) dated as of August 5, 2020 (the “Fourth Amendment Effective Date”) is entered into among ESTABLISHMENT LABS HOLDINGS INC., a BVI...Credit Agreement • August 10th, 2020 • Establishment Labs Holdings Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
THIRD AMENDMENT TO CREDIT AGREEMENT AND WAIVER THIS THIRD AMENDMENT TO CREDIT AGREEMENT AND WAIVER (this “Agreement”) dated as of June 17, 2019 (the “Third Amendment Effective Date”) is entered into among ESTABLISHMENT LABS HOLDINGS INC., a BVI...Credit Agreement • June 18th, 2019 • Establishment Labs Holdings Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
CREDIT AGREEMENT Dated as of February 28, 2019 among PORTOLA PHARMACEUTICALS, INC., as the Borrower, CERTAIN DOMESTIC SUBSIDIARIES OF THE BORROWER, as the Guarantors, HCR Collateral Management, LLC, as the Administrative Agent and THE LENDERS FROM...Credit Agreement • March 1st, 2019 • Portola Pharmaceuticals Inc • Pharmaceutical preparations • New York
CREDIT AGREEMENT Dated as of December 3, 2018 among DERMIRA, INC., as the Borrower, CERTAIN SUBSIDIARIES OF THE BORROWER, as the Guarantors, ATHYRIUM OPPORTUNITIES III ACQUISITION LP, as the Administrative Agent and THE LENDERS FROM TIME TO TIME PARTY...Credit Agreement • February 26th, 2019 • Dermira, Inc. • Pharmaceutical preparations • New York
This CREDIT AGREEMENT is entered into as of December 3, 2018 among DERMIRA, INC., a Delaware corporation (the “Borrower”), the Guarantors (defined herein), the Lenders (defined herein) and ATHYRIUM OPPORTUNITIES III ACQUISITION LP, as the Administrative Agent.
SECOND AMENDMENT TO CREDIT AGREEMENT AND WAIVERCredit Agreement • July 13th, 2018 • Establishment Labs Holdings Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
This CREDIT AGREEMENT is entered into as of August 24, 2017 among Establishment Labs Holdings Inc., a BVI business company, limited by shares and incorporated under the laws of the British Virgin Islands (the “Borrower”), the Guarantors (defined herein), the Lenders (defined herein) and MADRYN HEALTH PARTNERS, LP, a Delaware limited partnership, as the Administrative Agent.
SECOND AMENDMENT TO CREDIT AGREEMENT AND WAIVERCredit Agreement • June 21st, 2018 • Establishment Labs Holdings Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
This CREDIT AGREEMENT is entered into as of August 24, 2017 among Establishment Labs Holdings Inc., a BVI business company, limited by shares and incorporated under the laws of the British Virgin Islands (the “Borrower”), the Guarantors (defined herein), the Lenders (defined herein) and MADRYN HEALTH PARTNERS, LP, a Delaware limited partnership, as the Administrative Agent.
